This report contains market size and forecasts of Pomalidomide in global, including the following market information:
Global Pomalidomide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pomalidomide Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Pomalidomide companies in 2021 (%)
The global Pomalidomide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1mg Tables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pomalidomide include Celgene, Natco Pharma, Intas Pharmaceuticals, Indiabulls Pharmaceutical, Cipla, Glenmark Pharmaceuticals, Dr Reddy's Laboratories, Qilu Pharmaceutical and Chia Tai-Tianqing, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pomalidomide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pomalidomide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pomalidomide Market Segment Percentages, by Type, 2021 (%)
1mg Tables
2mg Tables
4mg Tables
Global Pomalidomide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pomalidomide Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug Center
Clinic
Other
Global Pomalidomide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pomalidomide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pomalidomide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pomalidomide revenues share in global market, 2021 (%)
Key companies Pomalidomide sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Pomalidomide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celgene
Natco Pharma
Intas Pharmaceuticals
Indiabulls Pharmaceutical
Cipla
Glenmark Pharmaceuticals
Dr Reddy's Laboratories
Qilu Pharmaceutical
Chia Tai-Tianqing
Hanson Pharm
Meidakang Huakang Pharmaceutical
Shandong Kongfu Pharmaceutical
SL PHARM